1. A soluble guanylate cyclase activator protects from diabetic nephropathy beyond standard of care in the ZSF1 rat. Issue 1 (December 2015) Authors: Pullen, Steven; Lincoln, Kathleen; Harrison, Paul; Chen, Hongxing; Wang, Hong; Clifford, Holly; Qian, HuSheng; Wong, Diane; Sarko, Chris; Brenneman, Jehrod; Fryer, Ryan; Richman, Jeremy; Reinhart, Glenn; Boustany, Carine Journal: BMC pharmacology & toxicology Issue: Volume 16:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of TRPC6 reduces systemic inflammation, cardiac fibrosis, and dramatically improves survival in dystrophic cardiomyopathy. (31st December 2022) Authors: Lin, Brian; Shin, Joseph; Jeffreys, Will; Lukban, Clarisse; Hanselman, Olivia; Kwon, Seoyoung; Wang, Nadan; Pullen, Steven; Filareto, Antonio; Kass, David Journal: Journal of molecular and cellular cardiology Issue: Volume 173(2022)Supplement Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Renal compartment–specific genetic variation analyses identify new pathways in chronic kidney disease. (November 2018) Authors: Qiu, Chengxiang; Huang, Shizheng; Park, Jihwan; Park, YoSon; Ko, Yi-An; Seasock, Matthew; Bryer, Joshua; Xu, Xiang-Xi; Song, Wen-Chao; Palmer, Matthew; Hill, Jon; Guarnieri, Paolo; Hawkins, Julie; Boustany-Kari, Carine; Pullen, Steven; Brown, Christopher; Susztak, Katalin Journal: Nature medicine Issue: Volume 24:Number 11(2018) Page Start: 1721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗